Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The clinical perspectives of CDX2 expression in colorectal cancer: a qualitative systematic review.

Surgical oncology - 1 Sept 2014

Olsen J, Espersen M L M, Jess P, Kirkeby L T, Troelsen J T

Abstract excerpt

INTRODUCTION: Homeobox genes are often deregulated in cancer. They can have both oncogenic and tumor-suppressing potential. The Caudal-related homeobox transcription factor 2 (CDX2) is an intestine-specific transcription factor. It is implicated in differentiation, proliferation, cell-adhesion, and migration. CDX2 has been proposed as a tumor suppressor in colorectal cancer but its role is still controversial....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma
Share to CDX2 Transcription Factor
Share to Cell Adhesion

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Movement

Share to Colorectal Neoplasms

Share to Homeodomain Proteins

Share to Tumor Microenvironment

Share to Wnt Signaling Pathway

Source

Identifiers

PMID: 25126956
DOI: 10.1016/j.suronc.2014.07.003

Genes

CDX2
BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The clinical perspectives of CDX2 expression in colorectal cancer: a qualitative systematic review.PMID 25126956Read ↗

The prognostic potential of CDX2 in colorectal cancer: Harmonizing biology and clinical practiceSemantic proximity Read ↗

Altered expression of CDX2 in colorectal cancersSemantic proximity Read ↗

Cdx2 Controls Expression of the Protocadherin Mucdhl, an Inhibitor of Growth and β-Catenin Activity in Colon Cancer CellsSemantic proximity Read ↗

Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients.Semantic proximity Read ↗

Relationship of CDX2 Loss with Molecular Features and Prognosis in Colorectal CancerSemantic proximity Read ↗

The Cdx2 homeobox gene suppresses intestinal tumorigenesis through non–cell-autonomous mechanismsSemantic proximity Read ↗

Methylation of CDX2 as a Predictor in Poor Clinical Outcome of Patients with Colorectal CancerSemantic proximity Read ↗

Expression and prognostic significance of CBX2 in colorectal cancer: Database mining for CBX family members in malignanciesSemantic proximity Read ↗

CDX2 controls genes involved in the metabolism of 5-fluorouracil and is associated with reduced efficacy of chemotherapy in colorectal cancerSemantic proximity Read ↗

CDX2 expression in the intestinal-type gastric epithelial neoplasia: frequency and significance.Semantic proximity Read ↗

CDX2 Loss With Microsatellite Stable Phenotype Predicts Poor Clinical Outcome in Stage II Colorectal CarcinomaSemantic proximity Read ↗

Comprehensive analysis of Distal-Less homeobox family gene expression in colon cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.